(3,4-dihydro-quinazolin-2-yl)-indan-1-yl-amines

摘要

The present invention relates to compounds of formula wherein R¹, R², and n are as defined herein and to pharmaceutically acceptable acid addition salts thereof. The compounds of formula I have a good activity on the 5-HT_5A receptor. Therefore, the invention provides the use of a compound of formula I for 5-HT_5A receptor related diseases, such as anxiety, depression, sleep disorders and schizophrenia.